Literature DB >> 27112699

Survival and growth of isolated pre-antral follicles from human ovarian medulla tissue during long-term 3D culture.

H Yin1, S G Kristensen2, H Jiang3, A Rasmussen2, C Yding Andersen4.   

Abstract

STUDY QUESTION: Can human pre-antral follicles isolated enzymatically from surplus medulla tissue survive and grow in vitro during long-term 3D culture? SUMMARY ANSWER: Secondary human follicles can develop to small antral follicles and remain hormonally active in an alginate-encapsulation culture system for more than 30 days. WHAT IS KNOWN ALREADY: Ovarian tissue cryopreservation followed by transplantation is a promising fertility preservation approach for cancer patients. However, transplantation of cryopreserved tissue to patients may carry the risk of re-implanting malignant cells. Grafting of follicles enzymatically isolated from ovarian tissue or developing a method for follicular culture and maturation in vitro may provide fertility to such patients without the risk of reintroducing the malignancy. However, the growth of pre-antral follicles isolated by enzymatic digestion from medulla tissue during long-term culture has received only little attention. STUDY DESIGN, SIZE, DURATION: Two to ten human pre-antral follicles were encapsulated together within an alginate bead and cultured with or without ovarian interstitial tissue for either 7 days or >30 days. Follicles were cultured in either 20% oxygen or 5% oxygen or encapsulated in a lower concentration of alginate together with a lower concentration of FSH in high oxygen. PARTICIPANTS/MATERIALS, SETTING,
METHODS: A total of 395 pre-antral follicles from 16 cancer patients, aged 9-37 years, were co-cultured for either 7 days or >30 days. A proportion of follicle (64) were removed from culture on Day 7 and assessed for viability using confocal fluorescence microscopy following calcein-AM and ethidium homodimer-1 staining or histology. The remaining follicles (331) were continued in culture for >30 days then assessed for survival and growth. Anti-Müllerian hormone (AMH) and estradiol levels were quantified in the medium. MAIN RESULTS AND THE ROLE OF CHANCE: An optimized protocol for isolation of intact healthy pre-antral follicles from ovarian medulla was developed. After 7 days of culture, secondary follicles had a significantly higher survival rates compared with primary and primordial follicles (70 versus <38%). Primordial and primary follicles did not develop into the antral follicle stage. In contrast, secondary follicles continued to develop in all culture conditions examined. Based on growth rate and morphology, four distinct cohorts of surviving follicles, 'fast growth', 'slow growth', 'no growth' and 'extruded oocyte' were identified. From Day 1 to Day 30, the mean diameter of follicles increased from 184 ± 35 to 661 ± 120 μm (significant from Day 18), 145 ± 19 to 318 ± 68 μm and 136 ± 15 to 162 ± 25 μm (mean ± SD) in the 'fast growth', 'slow growth' and 'no growth' patterns, respectively. The fast growth follicles also contained a larger diameter oocyte than other follicle groups. From the pre-antral follicle to antral stage, follicles became steroidogenically active and secretion of AMH and estradiol increased. No significant difference between the follicles cultured with or without ovarian interstitial tissue was observed. LIMITATIONS, REASONS FOR CAUTION: The number of surviving follicles at the end of study was low in each of the culture conditions therefore whether there is a benefit with any of the conditions is difficult to ascertain. Multiple pre-antral follicles were cultured within the same alginate bead which may affect the in vitro development of the secondary follicles. WIDER IMPLICATIONS OF THE
FINDINGS: These findings show that pre-antral follicles, isolated enzymatically from surplus medulla tissue that is normally discarded, possess a developmental potential which may be used to devise safer fertility preservation methods for patients who are at high risk of malignant contamination of their ovarian tissue. STUDY FUNDING/COMPETING INTERESTS: The Child Cancer Foundation in Denmark (2012-26) and the EU interregional project ReproHigh are thanked for having funded this study; and the Key Program of Medical Science and Technology Innovation of Nanjing Military Area Command in China (14ZX06; 11Z010). They had no role in the study design, collection and analysis of data, data interpretation or in writing the report. The authors have no conflicts of interest to disclose.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  fertility preservation; follicle culture; human follicle; isolation; ovarian medulla

Mesh:

Substances:

Year:  2016        PMID: 27112699     DOI: 10.1093/humrep/dew049

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

1.  Encapsulation of Mesenchymal Stem Cells in 3D Ovarian Cell Constructs Promotes Stable and Long-Term Hormone Secretion with Improved Physiological Outcomes in a Syngeneic Rat Model.

Authors:  Sivanandane Sittadjody; Kevin M Enck; Alexandra Wells; James J Yoo; Anthony Atala; Justin M Saul; Emmanuel C Opara
Journal:  Ann Biomed Eng       Date:  2019-07-31       Impact factor: 3.934

2.  Effects of vitrification on the viability of alginate encapsulated isolated bovine pre-antral follicles.

Authors:  Anniek Bus; Veerle van Hoeck; An Langbeen; Jo L M R Leroy; Peter E J Bols
Journal:  J Assist Reprod Genet       Date:  2018-05-24       Impact factor: 3.412

3.  Reconstitution of mouse oogenesis in a dish from pluripotent stem cells.

Authors:  Katsuhiko Hayashi; Orie Hikabe; Yayoi Obata; Yuji Hirao
Journal:  Nat Protoc       Date:  2017-08-10       Impact factor: 13.491

4.  Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles.

Authors:  S Lierman; K Tilleman; K Braeckmans; K Peynshaert; S Weyers; G T'Sjoen; P De Sutter
Journal:  J Assist Reprod Genet       Date:  2017-06-24       Impact factor: 3.412

5.  In vitro ovarian follicle growth: a comprehensive analysis of key protocol variables†.

Authors:  Leah E Simon; T Rajendra Kumar; Francesca E Duncan
Journal:  Biol Reprod       Date:  2020-08-21       Impact factor: 4.285

6.  Culture of human ovarian tissue in xeno-free conditions using laminin components of the human ovarian extracellular matrix.

Authors:  J Hao; A R Tuck; C R Prakash; A Damdimopoulos; M O D Sjödin; J Lindberg; B Niklasson; K Pettersson; O Hovatta; P Damdimopoulou
Journal:  J Assist Reprod Genet       Date:  2020-07-15       Impact factor: 3.412

7.  Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry.

Authors:  Tristan Zver; Elodie Mouloungui; Aurélie Berdin; Christophe Roux; Clotilde Amiot
Journal:  J Ovarian Res       Date:  2017-06-23       Impact factor: 4.234

8.  Is oxygen availability a limiting factor for in vitro folliculogenesis?

Authors:  Riccardo Talevi; Sam Sudhakaran; Vincenza Barbato; Anna Merolla; Sabrina Braun; Maddalena Di Nardo; Valentina Costanzo; Raffaele Ferraro; Nicola Iannantuoni; Gerardo Catapano; Roberto Gualtieri
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

9.  Comparison of the enzymatic efficiency of Liberase TM and tumor dissociation enzyme: effect on the viability of cells digested from fresh and cryopreserved human ovarian cortex.

Authors:  Viola Maria Schmidt; Vladimir Isachenko; Gunter Rappl; Gohar Rahimi; Bettina Hanstein; Bernd Morgenstern; Peter Mallmann; Evgenia Isachenko
Journal:  Reprod Biol Endocrinol       Date:  2018-06-02       Impact factor: 5.211

Review 10.  Cryopreservation of Ovarian Tissue: Opportunities Beyond Fertility Preservation and a Positive View Into the Future.

Authors:  Stine G Kristensen; Claus Y Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.